JP2020535796A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020535796A5 JP2020535796A5 JP2020513309A JP2020513309A JP2020535796A5 JP 2020535796 A5 JP2020535796 A5 JP 2020535796A5 JP 2020513309 A JP2020513309 A JP 2020513309A JP 2020513309 A JP2020513309 A JP 2020513309A JP 2020535796 A5 JP2020535796 A5 JP 2020535796A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- fusion protein
- seq
- cell
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023003704A JP2023029624A (ja) | 2017-09-06 | 2023-01-13 | ｓｔｒｅｐタグ特異的キメラ受容体およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762555012P | 2017-09-06 | 2017-09-06 | |
| US62/555,012 | 2017-09-06 | ||
| PCT/US2018/049804 WO2019051128A1 (en) | 2017-09-06 | 2018-09-06 | SPECIFIC STREP LABEL CHIMERIC RECEPTORS AND USES THEREOF |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023003704A Division JP2023029624A (ja) | 2017-09-06 | 2023-01-13 | ｓｔｒｅｐタグ特異的キメラ受容体およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020535796A JP2020535796A (ja) | 2020-12-10 |
| JP2020535796A5 true JP2020535796A5 (https=) | 2021-10-14 |
| JP7407701B2 JP7407701B2 (ja) | 2024-01-04 |
Family
ID=63788013
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020513309A Active JP7407701B2 (ja) | 2017-09-06 | 2018-09-06 | ｓｔｒｅｐタグ特異的キメラ受容体およびその使用 |
| JP2023003704A Pending JP2023029624A (ja) | 2017-09-06 | 2023-01-13 | ｓｔｒｅｐタグ特異的キメラ受容体およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023003704A Pending JP2023029624A (ja) | 2017-09-06 | 2023-01-13 | ｓｔｒｅｐタグ特異的キメラ受容体およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20210023132A1 (https=) |
| EP (1) | EP3679072A1 (https=) |
| JP (2) | JP7407701B2 (https=) |
| CN (1) | CN111051349A (https=) |
| AU (1) | AU2018327225A1 (https=) |
| CA (1) | CA3071661A1 (https=) |
| WO (1) | WO2019051128A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113354744A (zh) | 2013-12-20 | 2021-09-07 | 弗雷德哈钦森癌症研究中心 | 带标签的嵌合效应分子及其受体 |
| EP3288570A4 (en) | 2015-04-29 | 2018-11-21 | Fred Hutchinson Cancer Research Center | Modified stem cells and uses thereof |
| FI3909972T3 (fi) | 2015-06-19 | 2024-05-03 | Sebastian Kobold | Pd1-cd28-fuusioproteiineja ja niiden käyttö lääkkeessä |
| WO2019222642A1 (en) * | 2018-05-18 | 2019-11-21 | Senti Biosciences, Inc. | Engineered immune cells and methods of use |
| CN111944050B (zh) * | 2020-08-19 | 2022-05-13 | 苏州普乐康医药科技有限公司 | 一种抗b7-h3抗体及其应用 |
| CN112250767B (zh) * | 2020-12-08 | 2021-05-18 | 北京艺妙神州医药科技有限公司 | 一种结合Strep-Tag II标签的抗体及其应用 |
| CN115368470A (zh) * | 2021-05-21 | 2022-11-22 | 南京卡提医学科技有限公司 | 靶向b7-h3的嵌合受体及其用途 |
| WO2023081727A1 (en) * | 2021-11-02 | 2023-05-11 | Fred Hutchinson Cancer Center | Treatments for cancers utilizing cell-targeted therapies and associated research protocols |
| WO2024152962A1 (zh) * | 2023-01-18 | 2024-07-25 | 贝达药业股份有限公司 | 抗tt3的人源化抗体及其应用 |
| WO2024240064A1 (zh) * | 2023-05-19 | 2024-11-28 | 贝达药业股份有限公司 | 靶向抗原表位多肽的抗体药物偶联物及其应用 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5283173A (en) | 1990-01-24 | 1994-02-01 | The Research Foundation Of State University Of New York | System to detect protein-protein interactions |
| US5420032A (en) | 1991-12-23 | 1995-05-30 | Universitge Laval | Homing endonuclease which originates from chlamydomonas eugametos and recognizes and cleaves a 15, 17 or 19 degenerate double stranded nucleotide sequence |
| US5792632A (en) | 1992-05-05 | 1998-08-11 | Institut Pasteur | Nucleotide sequence encoding the enzyme I-SceI and the uses thereof |
| US7067318B2 (en) | 1995-06-07 | 2006-06-27 | The Regents Of The University Of Michigan | Methods for transfecting T cells |
| WO2000023573A2 (en) | 1998-10-20 | 2000-04-27 | City Of Hope | Cd20-specific redirected t cells and their use in cellular immunotherapy of cd20+ malignancies |
| DE10113776B4 (de) | 2001-03-21 | 2012-08-09 | "Iba Gmbh" | Isoliertes streptavidinbindendes, kompetitiv eluierbares Peptid, dieses umfassendes Fusionspeptid, dafür codierende Nukleinsäure, Expressionsvektor, Verfahren zur Herstellung eines rekombinanten Fusionsproteins und Verfahren zum Nachweis und/oder zur Gewinnung des Fusionsproteins |
| US7070995B2 (en) | 2001-04-11 | 2006-07-04 | City Of Hope | CE7-specific redirected immune cells |
| US7514537B2 (en) | 2001-04-30 | 2009-04-07 | City Of Hope | Chimeric immunoreceptor useful in treating human gliomas |
| US20060078552A1 (en) | 2002-03-15 | 2006-04-13 | Sylvain Arnould | Hybrid and single chain meganucleases and use thereof |
| US20060153826A1 (en) | 2003-01-28 | 2006-07-13 | Sylvain Arnould | Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof |
| JP2008527001A (ja) | 2005-01-13 | 2008-07-24 | ザ ジョンズ ホプキンス ユニバーシティー | 前立腺幹細胞抗原ワクチンおよびその使用 |
| CA2891996A1 (en) | 2005-10-18 | 2007-04-26 | Duke University | Rationally-designed meganucleases with altered sequence specificity and dna-binding affinity |
| CA2656379A1 (en) * | 2006-06-21 | 2007-12-27 | Apogenix Gmbh | Differential cytokine expression in human cancer |
| WO2008042814A2 (en) | 2006-09-29 | 2008-04-10 | California Institute Of Technology | Mart-1 t cell receptors |
| KR101319499B1 (ko) | 2008-02-22 | 2013-10-17 | 엘지디스플레이 주식회사 | 화학적 자기조립 방법을 이용한 나노선 혹은탄소나노튜브의 적층 및 패턴형성 방법과, 이를 적용한액정표시장치의 제조방법 |
| US20110189194A1 (en) * | 2008-07-14 | 2011-08-04 | Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts | Use of cd95 inhibitors for the treatment of inflammatory disorders |
| EP4032552B1 (en) | 2008-08-26 | 2023-10-04 | City of Hope | Method and compositions for enhanced anti-tumor effector functioning of t cells |
| EP2210903A1 (en) | 2009-01-21 | 2010-07-28 | Monoclonal Antibodies Therapeutics | Anti-CD160 monoclonal antibodies and uses thereof |
| EP2258719A1 (en) | 2009-05-19 | 2010-12-08 | Max-Delbrück-Centrum für Molekulare Medizin (MDC) | Multiple target T cell receptor |
| JP6208580B2 (ja) | 2010-05-17 | 2017-10-04 | サンガモ セラピューティクス， インコーポレイテッド | 新規のｄｎａ結合タンパク質及びその使用 |
| JP6120848B2 (ja) | 2011-08-15 | 2017-04-26 | メディミューン，エルエルシー | 抗ｂ７−ｈ４抗体およびその使用 |
| EP3241902B1 (en) | 2012-05-25 | 2018-02-28 | The Regents of The University of California | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription |
| KR101342974B1 (ko) * | 2012-11-06 | 2013-12-18 | 명지대학교 산학협력단 | 신규 펩티드 태그 및 이의 용도 |
| CA2881981A1 (en) | 2012-08-20 | 2014-02-27 | Fred Hutchinson Cancer Research Center | Method and compositions for cellular immunotherapy |
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| WO2014093718A1 (en) | 2012-12-12 | 2014-06-19 | The Broad Institute, Inc. | Methods, systems, and apparatus for identifying target sequences for cas enzymes or crispr-cas systems for target sequences and conveying results thereof |
| AU2013361275B2 (en) | 2012-12-19 | 2016-11-24 | Amplimmune, Inc. | Anti-human B7-H4 antibodies and their uses |
| EP2871189A1 (en) | 2013-11-07 | 2015-05-13 | Institut Pasteur | High-affinity monoclonal anti-strep-tag antibody |
| EP3760719A1 (en) | 2013-11-18 | 2021-01-06 | CRISPR Therapeutics AG | Crispr-cas system materials and methods |
| CN113354744A (zh) * | 2013-12-20 | 2021-09-07 | 弗雷德哈钦森癌症研究中心 | 带标签的嵌合效应分子及其受体 |
| US20160333108A1 (en) | 2014-01-13 | 2016-11-17 | Stephen J. Forman | CHIMERIC ANTIGEN RECEPTORS (CARs) HAVING MUTATIONS IN THE FC SPACER REGION AND METHODS FOR THEIR USE |
| JP6943760B2 (ja) | 2014-09-12 | 2021-10-06 | ジェネンテック， インコーポレイテッド | 抗ｂ７−ｈ４抗体及び免疫複合体 |
| JP2017531427A (ja) | 2014-10-03 | 2017-10-26 | デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド | グルココルチコイド誘導腫瘍壊死因子受容体（ｇｉｔｒ）抗体およびその使用法 |
| US10227408B2 (en) | 2015-02-19 | 2019-03-12 | Compugen Ltd. | Anti-PVRIG antibodies and methods of use |
| WO2016176651A2 (en) * | 2015-04-29 | 2016-11-03 | Fred Hutchinson Cancer Research Center | Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof |
| JO3620B1 (ar) | 2015-08-05 | 2020-08-27 | Amgen Res Munich Gmbh | مثبطات نقطة فحص مناعية للاستخدام في علاج سرطانات محمولة عبر الدم |
| MX2019008538A (es) * | 2017-01-20 | 2019-11-05 | Juno Therapeutics Gmbh | Conjugados de superficie celular y composiciones y métodos celulares relacionados. |
| AU2018327229A1 (en) | 2017-09-06 | 2020-02-27 | Fred Hutchinson Cancer Center | Strep-tag specific binding proteins and uses thereof |
-
2018
- 2018-09-06 JP JP2020513309A patent/JP7407701B2/ja active Active
- 2018-09-06 WO PCT/US2018/049804 patent/WO2019051128A1/en not_active Ceased
- 2018-09-06 CA CA3071661A patent/CA3071661A1/en active Pending
- 2018-09-06 CN CN201880057804.1A patent/CN111051349A/zh active Pending
- 2018-09-06 EP EP18782835.5A patent/EP3679072A1/en not_active Withdrawn
- 2018-09-06 AU AU2018327225A patent/AU2018327225A1/en not_active Abandoned
- 2018-09-06 US US16/644,947 patent/US20210023132A1/en not_active Abandoned
-
2023
- 2023-01-13 JP JP2023003704A patent/JP2023029624A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020535796A5 (https=) | ||
| KR102879284B1 (ko) | 항-메소텔린 키메라 항원 수용체(car) 작제물 및 이의 용도 | |
| JP6840682B2 (ja) | 多重特異的抗原結合タンパク質 | |
| JP7082574B2 (ja) | 免疫療法用改変細胞 | |
| JP6722189B2 (ja) | 単量体Ｆｃドメイン | |
| JP6702893B2 (ja) | 多重特異的抗原結合タンパク質 | |
| JP2023078394A (ja) | Ｃａｒ－ｔ細胞の調節方法 | |
| CN112794916B (zh) | 三特异性抗原结合构建体及构建方法和应用 | |
| CA3075619A1 (en) | Methods and systems for performing a patient-specific immunotherapy procedure with chain-of-custody and chain-of-identity biological sample tracking | |
| KR20200015713A (ko) | 항-trbc1 항원 결합 도메인 | |
| CA3030837A1 (en) | Treatment and prevention of cytokine release syndrome using a chimeric antigen receptor in combination with a kinase inhibitor | |
| KR20220035367A (ko) | 항-dll3 키메라 항원 수용체 및 이의 용도 | |
| CN110088133A (zh) | 抗独特型抗体及相关方法 | |
| JP2019503200A (ja) | 癌の治療のための組成物及び方法 | |
| RU2019126655A (ru) | Нуклеиновые кислоты, кодирующие химерные рецепторы, полипептидные химерные рецепторы, кодируемые ими, векторы экспрессии, содержащие их, выделенные клетки-хозяева, содержащие их, композиции, содержащие выделенные клетки-хозяева, а также способы получения выделенных клеток-хозяев in vitro, способы выбора нуклеиновых кислот, кодирующих химерные рецепторы, in vitro и способы проведения клеточной иммунотерапии у субъекта, имеющего опухоль | |
| CA3223034A1 (en) | Anti-cd307e single-domain antibodies, uses thereof in car t-cell and for the treatment of diseases | |
| CN114206919B (zh) | 靶向taci的抗体和嵌合抗原受体 | |
| JP2020530859A (ja) | 免疫調節剤としてのｃｄ９６結合剤 | |
| CA3079363A1 (en) | Multispecific antigen binding proteins | |
| US20200262894A1 (en) | Strep-tag specific binding proteins and uses thereof | |
| JP2023542900A (ja) | ４－１ｂｂを標的とする単一ドメイン抗体、その融合タンパク質、その医薬組成物及び使用 | |
| WO2023246911A1 (zh) | 基于t细胞受体的双特异性多肽分子及其用途 | |
| WO2025251924A1 (zh) | 特异性结合cd3/tcr复合物的纳米抗体或其抗原结合片段及其应用 | |
| WO2025087436A1 (zh) | 基于t细胞受体的多特异性多肽分子及其组合物和用途 | |
| HK40077185A (en) | Methods and systems for performing a patient-specific immunotherapy procedure with chain-of-custody and chain-of-identity biological sample tracking |